VALENCE TECHNOLOGY (VLNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : VALENCE TECHNOLOGY (VLNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mooter775 who wrote (19118)	4/9/2000 7:15:00 PM
From: Socalsteve	Read Replies (1) of 27311

Mooter...OT I believe it is significant that ALLP's Oxygent is the only blood substitute in clinical trials not derived from human or animal blood. ALLP is in Phase 3 in Europe and US. I would expect a rather rapid approval (12-14 months) to take place in Europe as the need is rather urgent, with the UK's Mad Cow contaminant and France's release of un-screened blood last year. I for one would be a little hesitant to receive any blood from any source other than my family if I were in need, and in Europe. I am long this stock in case anyone is curious. Sorry thread for sidetracking the subject. Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next